BioRestorative Therapies, Inc. (NASDAQ:BRTX) Short Interest Update

BioRestorative Therapies, Inc. (NASDAQ:BRTX) was the target of a large growth in short interest in January. As of January 31st, there was short interest totalling 235,600 shares, a growth of 81.0% from the January 15th total of 130,200 shares. Approximately 4.6% of the company’s shares are short sold. Based on an average daily volume of 72,300 shares, the short-interest ratio is presently 3.3 days.

BioRestorative Therapies Stock Up 2.3 %

Shares of NASDAQ BRTX traded up $0.06 during midday trading on Thursday, hitting $2.45. The stock had a trading volume of 18,035 shares, compared to its average volume of 71,513. The company has a market capitalization of $16.92 million, a price-to-earnings ratio of -1.60 and a beta of 62.62. BioRestorative Therapies has a 1-year low of $1.03 and a 1-year high of $2.55. The company has a fifty day moving average price of $1.84 and a 200 day moving average price of $1.67.

BioRestorative Therapies (NASDAQ:BRTX) last released its quarterly earnings data on Tuesday, November 12th. The company reported ($0.13) earnings per share for the quarter, beating the consensus estimate of ($0.35) by $0.22. The business had revenue of $0.23 million for the quarter, compared to analyst estimates of $0.30 million. BioRestorative Therapies had a negative return on equity of 98.49% and a negative net margin of 2,697.08%. On average, research analysts forecast that BioRestorative Therapies will post -1.43 EPS for the current year.

About BioRestorative Therapies

BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.